Top
FBXL5 has not been detected as a mutational cancer driver

FBXL5
Ensembl id ENSG00000118564
Mutated samples
Coding Sequence 33 (0.5%)
Protein Affecting 23 (0.3%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all FBXL5 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 7 6 1.63
Breast carcinoma No 6 4 0.35
Lung adenocarcinoma No 2 2 0.51
Glioblastoma multiforme No 2 2 0.53
Lung squamous cell carcinoma No 1 1 0.57
Pancreas adenocarcinoma No 2 1 0.47
Uterine corpus endometrioid carcinoma No 1 1 0.43
Serous ovarian adenocarcinoma No 1 1 0.32
Stomach adenocarcinoma No 2 1 0.62
Small cell lung carcinoma No 1 1 1.45
Head and neck squamous cell carcinoma No 1 1 0.27
Diffuse B cell lymphoma No 2 1 4.35
Esophageal carcinoma No 1 1 0.68
Hepatocarcinoma No 1 0 0.00
Bladder carcinoma No 2 0 0.00
Chronic lymphocytic leukemia No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence